Figure 8
Figure 8. Zoledronate plus IL-2 efficiently expands γδ T cells in the CD56+ cell subset. CD56+ cells (1.5 × 106/mL) were stimulated with either IL-2 alone (100 U/mL) or with zoledronate (1 μM) plus IL-2. Fresh complete medium containing IL-2 was added every 3 days. After 14 days of expansion, cells were harvested, counted, and analyzed for Vδ2+ T-cell frequency by flow cytometry. (A) Plots of CD3 expression against Vδ2 expression show Vδ2+ T cells in freshly isolated CD56+ cells and show efficient expansion with zoledronate plus IL-2 but not with IL-2 alone. (B) Depletion of CD14+ cells before stimulation with zoledronate and IL-2 resulted in substantially diminished γδ T-cell expansion. Data are representative of 3 independent experiments with different donors. Numbers in the upper right quadrants indicate the frequency (in %) of Vδ2+ T cells.

Zoledronate plus IL-2 efficiently expands γδ T cells in the CD56+ cell subset. CD56+ cells (1.5 × 106/mL) were stimulated with either IL-2 alone (100 U/mL) or with zoledronate (1 μM) plus IL-2. Fresh complete medium containing IL-2 was added every 3 days. After 14 days of expansion, cells were harvested, counted, and analyzed for Vδ2+ T-cell frequency by flow cytometry. (A) Plots of CD3 expression against Vδ2 expression show Vδ2+ T cells in freshly isolated CD56+ cells and show efficient expansion with zoledronate plus IL-2 but not with IL-2 alone. (B) Depletion of CD14+ cells before stimulation with zoledronate and IL-2 resulted in substantially diminished γδ T-cell expansion. Data are representative of 3 independent experiments with different donors. Numbers in the upper right quadrants indicate the frequency (in %) of Vδ2+ T cells.

Close Modal

or Create an Account

Close Modal
Close Modal